Strides Pharma Science Revenue

Strides Pharma Science had revenue of 10.88B INR in the quarter ending June 30, 2024, with 16.94% growth. This brings the company's revenue in the last twelve months to 42.09B, up 14.42% year-over-year. In the fiscal year ending March 31, 2024, Strides Pharma Science had annual revenue of 40.51B with 9.83% growth.

Revenue (ttm)

42.09B

Revenue Growth

+14.42%

P/S Ratio

2.95

Revenue / Employee

14.77M

Employees

2,850

Market Cap

125.04B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2024	40.51B	3.63B	9.83%
Mar 31, 2023	36.88B	6.18B	20.13%
Mar 31, 2022	30.70B	-2.46B	-7.41%
Mar 31, 2021	33.16B	5.64B	20.49%
Mar 31, 2020	27.52B	5.74B	26.33%
Mar 31, 2019	Pro	Pro	Pro
Mar 31, 2018	Pro	Pro	Pro
Mar 31, 2017	Pro	Pro	Pro
Mar 31, 2016	Pro	Pro	Pro
Mar 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Reliance Industries Limited	9,252.89B
Tata Consultancy Services Limited	2,441.25B
HDFC Bank Limited	2,663.37B
Bharti Airtel Limited	1,510.49B
ICICI Bank Limited	1,686.78B
Infosys Limited	1,555.41B
State Bank of India	3,319.63B
Hindustan Unilever Limited	621.07B

Revenue Rankings

Strides Pharma Science News

2 days ago - Strides Pharma Science share jumps 2.62% after getting USFDA approval for Theophylline Extended-Release tablets - Business Upturn
2 days ago - Strides Pharma Science gets USFDA nod for Theophylline Extended-Release tablets - Business Upturn
22 days ago - Strides Pharma Science shares at 9-year high after US subsidiary closure - Business Upturn

More News